3696 News

Eli Lilly pays $115m upfront for AI drug pipeline in deal worth up to $2.75bn

Eli Lilly has signed a global R&D collaboration with Hong Kong-listed Insilico Medicine, an AI-driven clinical-stage biotechnology company, valued at...